Tetrahydrocinnolines as 11 beta HSD1 inhibitors for diabetes

Details for Australian Patent Application No. 2009272895 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Kuhn, Bernd; Amrein, Kurt; Mayweg, Alexander V.; Neidhart, Werner; Ackermann, Jean

Agent Spruson & Ferguson

Pub. Number AU-A-2009272895

PCT Pub. Number WO2010/006940

Priority 08160446.4 15.07.08 EP

Filing date 6 July 2009

Wipo publication date 21 January 2010

International Classifications

C07D 237/28 (2006.01) Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

A61K 31/502 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

6 January 2011 PCT application entered the National Phase

  PCT publication WO2010/006940 Priority application(s): WO2010/006940

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009272898-Discharge spout for flexible bags

2009272893-Novel heterocyclyl compounds for treatment of cardiovascular disease